from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2751/-

LFCtreatmentdescriptionclass of inhibitor

-0.307

Amikacinug/mL Amikacintranslation

-0.112

Cap5-10ug/mL Capreomycintranslation

-0.382

Rox10-50 ug/mL Roxithromycintranslation

-0.476

SM2-5 ug/mL Streptomycintranslation

-1.084

Tet5-10 ug/mL Tetracyclinetranslation

0.470

Rif0.2-5ug/mL Rifampicintranscription

-0.188

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.603

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.449

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.621

CPZ10-50 ug/mL Chlorpromazinerespiration

1.175

Clofazimine10-13 ug/mL Clofaziminerespiration

0.748

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.337

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.204

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.170

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.004

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.354

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.524

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.627

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.240

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.465

KCN5-20 ug/mL Potassium cyaniderespiration

0.035

NaN30.2-2 mM Sodium aziderespiration

0.189

Nigericin50 uM Nigericinrespiration

0.517

TRC10-150 ug/mL Triclosanrespiration

0.515

TRZ10-25 ug/mL Thioridazinerespiration

-2.040

Valinomycin0.5-10 uM Valinomycinrespiration

1.715

ZnSO42 mM ZnSO4respiration

0.266

menadione6-10 ug/mL Menadionerespiration

0.216

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.190

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.114

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.324

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.068

NRP_1Non-replicating persistence stage 1dosRassociated

-0.417

Amp0.2mg/mL AmpicillincellWall

0.018

Cephalexin20-100 ug/mL CephalexincellWall

-0.184

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.523

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.519

EMB10-20 ug/mL EthambutolcellWall

-0.332

Eta12-40 ug/mL EthionamidecellWall

-0.561

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.049

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.239

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.443

BZA0.12 mg/mL BenzamidearomaticAmides

-0.727

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.563

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.413

H2O24 mM hydrogen peroxideDNAdamaging

0.293

Levo10 ug/mL LevofloxacinDNAdamaging

-0.712

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.748

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.107

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.383

UVUV-irradiationDNAdamaging

-0.042

ARP41-4 ug/mL Antitubercular compound ARP4?

0.165

Antimycin12.5-50 ug/mL Antimycin A?

0.046

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.656

PA_110-50 ug/mL Antitubercular compound PA-1?

0.181

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.943

PA8240.2-2 ug/mL PA-824?

0.668

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.707

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.093

Verapamil50 uM Verapamil?

0.115

mercaptoethanol2 mM 2-Mercaptoethanol?

0.423

methoxatin10-20 ug/mL Methoxatin?